SCHEMBL6608975

SCHEMBL6608975

C[C@@]1(NC(=O)O)CCNC1=O

nearest known ligand 0.41

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
HPGDS O60760 1/20 0.41
APOL1 O14791 2/20 0.37
METAP2 P50579 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17163848 1.00 HPGDS (0.41) HPGDSAPOL1METAP2
SCHEMBL7394465 0.76 HPGDS (0.40) HPGDSAPOL1
SCHEMBL23987187 0.71 HPGDS (0.34) HPGDSAPOL1METAP2
SCHEMBL25589899 0.71 HPGDS (0.32) HPGDS
SCHEMBL26670550 0.70 METAP2 (0.33) METAP2
SCHEMBL17611616 0.69 FFAR3 (0.37) METAP2
SCHEMBL25776149 0.69 FFAR3 (0.37) METAP2
SCHEMBL14019259 0.67 GAA (0.35) HPGDS
SCHEMBL318739 0.67 CCR2 (0.35)
SCHEMBL3738807 0.66

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1458684-A2 THERAPEUTIC HETEROCYCLES AstraZeneca AB (SE) 2004-09-22 EP disclosed
WO-2003051276-A2 THERAPEUTIC HETEROCYCLES ASTRAZENECA AB (SE) 2003-06-26 WO disclosed